Edesa Biotech, Inc.
EDSA
$4.72
-$0.01-0.21%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.10M | -10.44M | -7.82M | -7.19M | -5.92M |
| Total Depreciation and Amortization | 102.90K | 103.10K | 101.70K | 119.30K | 137.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.84M | 1.47M | 1.05M | 729.70K | 419.20K |
| Change in Net Operating Assets | 3.25M | 1.35M | -1.23M | -985.60K | -1.21M |
| Cash from Operations | -8.91M | -7.53M | -7.89M | -7.32M | -6.57M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 7.22M | 3.72M | 10.59M | 7.72M | 7.50M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 8.34M | 9.88M | 9.88M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -238.50K | -185.40K | -613.90K | -567.50K | -564.90K |
| Cash from Financing | 6.98M | 3.53M | 18.31M | 17.03M | 16.81M |
| Foreign Exchange rate Adjustments | -101.40K | 99.80K | 65.90K | 46.20K | 76.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.03M | -3.89M | 10.49M | 9.75M | 10.32M |